Clinical trial

Bempegaldesleukin and Pembrolizumab With or Without Chemotherapy in Locally Advanced or Metastatic Solid Tumors

NCT03138889

Study summary

ClinicalTrials.gov

Bempegaldesleukin and Pembrolizumab With or Without Chemotherapy in Locally Advanced or Metastatic Solid Tumors

Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE1, PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

10 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention NKTR-214 Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Pembrolizumab Normalized identity: pembrolizumab View linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention NKTR-214 Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Cisplatin Normalized identity: cisplatin View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Carboplatin Normalized identity: carboplatin View linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Nab paclitaxel Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Paclitaxel Normalized identity: paclitaxel View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Pemetrexed Normalized identity: pemetrexed View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Atezolizumab Normalized identity: atezolizumab View linked drug · Find medicine records · Find other trials using this name

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2017-06-09

PhasePHASE1 / PHASE2

Conditions

Non-Small Cell Lung Cancerverified · MONDO: non-small cell lung carcinoma

Interventions

NKTR-214DRUG

PembrolizumabDRUG · verified · RxNorm: pembrolizumab

NKTR-214DRUG

CisplatinDRUG · verified · RxNorm: cisplatin

CarboplatinDRUG · verified · RxNorm: carboplatin

Nab paclitaxelDRUG

PaclitaxelDRUG · verified · RxNorm: paclitaxel

PemetrexedDRUG · verified · RxNorm: pemetrexed

AtezolizumabDRUG · verified · RxNorm: atezolizumab

Sponsors & collaborators

Nektar Therapeuticslead sponsor

Mapped research locations

MadridSpain3 New YorkNew York, United States2 BarcelonaSpain2 HoustonTexas, United States1 PhiladelphiaPennsylvania, United States1 St LouisMissouri, United States1 NashvilleTennessee, United States1 San FranciscoCalifornia, United States1 BerlinGermany1 DurhamNorth Carolina, United States1 AuroraColorado, United States1 DetroitMichigan, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03138889 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.